long-term outcomes of subjects with ebv driven ptld following solid organ or allogeneic hct trea...
Published 4 years ago • 665 plays • Length 10:47Download video MP4
Download video MP3
Similar videos
-
2:21
tab-cel for solid organ or allogeneic transplant recipients with ebv-ptld
-
1:58
clinical outcomes of patients with ebv-ptld who fail rituximab following hsct
-
6:01
update on allele: tab-cel in patients with ebv ptld following allosct after rituximab failure
-
4:47
epstein-barr virus associated post-transplant lymphoproliferative disorder (ebv ptld)
-
55:06
organ function and long-term outcomes following hemopoietic stem cell transplants for scid
-
1:35
long-term outcomes for patients with ptcl: 10-year follow-up analysis
-
1:56
strategies for the management of ebv-ptld
-
4:16
rituximab induction is a predictive biomarker in post-transplant lymphoproliferative disorder
-
1:16
predictors of long-term survival in patients with dlbcl/hgbcl following autosct
-
1:05
long-term outcomes of patients with cll treated with continuous ibrutinib
-
2:41
cytotoxic t lymphocyte cell therapy directed against ebv ptld in the central nervous system
-
6:09
mohamad mohty, ash 2018 – epstein-barr virus and cytotoxic t lymphocyte therapy
-
2:59
tabelecleucel in ebv-associated ptld
-
1:28:45
ptld
-
14:37
atara biotherapeutics
-
2:03
the role of epstein-barr virus in the pathogenesis of ms
-
3:36
outcomes of patients with newly diagnosed crlf2-rearranged b-all
-
0:48
the role of transplantation in ph all patients treated with chemotherapy-free regimens
-
1:25
safety and efficacy of linvoseltamab for patients with r/r multiple myeloma